Bronchiectasis
📧 Sign up to get email alerts when something new happens for Bronchiectasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-09-29Clinical Trial Update: Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis [Phase 4]
Phase 4 trial investigating immunoglobulin replacement for IgG subclass 2 deficiency with bronchiectasis has been withdrawn.
-
EMA withdrawal · 2020-01-24EMA Application withdrawn: Linhaliq — Aradigm Pharmaceuticals Limited
The EMA withdrew the application for Linhaliq by Aradigm Pharmaceuticals Limited for bronchiectasis.
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: Pain Mechanisms in Patients With Bronchiectasis
A clinical trial investigating pain mechanisms in patients with bronchiectasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-18Clinical Trial Update: Bronchiectasis: Evaluation of an Educational Intervention
A clinical trial evaluating an educational intervention for bronchiectasis was withdrawn from the registry.